Author:
Kaatz Scott,Kouides Peter A.,Garcia David A.,Spyropolous Alex C.,Crowther Mark,Douketis Jim D.,Chan Anthony K. C.,James Andra,Moll Stephan,Ortel Thomas L.,Van Cott Elizabeth M.,Ansell Jack
Reference36 articles.
1. Boehringer Ingelheim Pharmaceuticals Inc 2012 http://bidocs.boehringer-ingelheim.com/BIWebAccess/ViewServlet.ser?docBase=renetnt &folderPath=/Prescribing%20Information/PIs/Pradaxa/Pradaxa.pdf
2. Janssen Pharmaceuticals Inc 2011 http://www.xareltohcp.com/sites/default/files/pdf/xarelto_0.pdf#zoom=100
3. Husten L 2011 http://www.forbes.com/sites/larryhusten/2011/11/29/apixaban-gains-priority-fda-review-for-stroke-and-vte-prevention-in-af/
4. Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients;Goldhaber;N Engl J Med,2011
Cited by
318 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献